APA (7th ed.) Citation

Mok, T., Gorbunova, V., Juhasz, E., Szima, B., Burdaeva, O., Orlov, S., . . . Reck, M. (2014). A Correlative Biomarker Analysis of the Combination of Bevacizumab and Carboplatin-Based Chemotherapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: Results of the Phase II Randomized ABIGAIL Study (BO21015). Journal of thoracic oncology, 9(6), 848-855. https://doi.org/10.1097/JTO.0000000000000160

Chicago Style (17th ed.) Citation

Mok, Tony, et al. "A Correlative Biomarker Analysis of the Combination of Bevacizumab and Carboplatin-Based Chemotherapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: Results of the Phase II Randomized ABIGAIL Study (BO21015)." Journal of Thoracic Oncology 9, no. 6 (2014): 848-855. https://doi.org/10.1097/JTO.0000000000000160.

MLA (9th ed.) Citation

Mok, Tony, et al. "A Correlative Biomarker Analysis of the Combination of Bevacizumab and Carboplatin-Based Chemotherapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: Results of the Phase II Randomized ABIGAIL Study (BO21015)." Journal of Thoracic Oncology, vol. 9, no. 6, 2014, pp. 848-855, https://doi.org/10.1097/JTO.0000000000000160.